<html>
<head>PUBMED IDs for HPC2</head>
<body bgcolor='#C5F0F2'><h1>HPC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9584199/'>Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.</a> June 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9858326/'>Hereditary prostate cancer in African-American families.</a> December 19  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9858600/'>C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins.</a> December 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9858531/'>RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.</a> December 22  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10581039/'>Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation.</a> December 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10617669/'>Transcriptional repression mediated by polycomb group proteins and other chromatin-associated repressors is selectively blocked by insulators.</a> January 5  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10825164/'>HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.</a> May 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10986046/'>Association of HPC2/ELAC2 genotypes and prostate cancer.</a> September 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254449/'>HPC2 variants and screen-detected prostate cancer.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254448/'>Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11409871/'>Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families.</a> June 21  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11431329/'>Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.</a> June 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11433415/'>No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer.</a> July 4  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11507049/'>ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.</a>  8  Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33101 Tampere, Finland. loanro@uta.fi,<br><a href='https://pubmed.ncbi.nlm.nih.gov/11522646/'>Role of HPC2/ELAC2 in hereditary prostate cancer.</a> August 28  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11673416/'>Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.</a> October 24  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12085959/'>Prostate cancer susceptibility genes: many studies, many results, no answers.</a> June 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12101246/'>Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins.</a> July 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12193277/'>A panel of monoclonal antibodies against human polycomb group proteins.</a> August 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12373607/'>HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.</a> October 10  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12482919/'>Polycomb group gene silencing proteins are concentrated in the perichromatin compartment of the mammalian nucleus.</a> December 17  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12515253/'>Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12522685/'>Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.</a> January 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12524332/'>Defects in SPT16 or POB3 (yFACT) in Saccharomyces cerevisiae cause dependence on the Hir/Hpc pathway: polymerase passage may degrade chromatin structure.</a> January 14  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12552947/'>Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.</a> January 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12783937/'>ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.</a> June 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12790786/'>Prostate cancer susceptibility genes: lessons learned and challenges posed.</a> June 7  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12829790/'>MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.</a> June 28  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12949798/'>Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.</a> September 2  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14504198/'>Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.</a> September 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601030/'>Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601029/'>Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601028/'>Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14625808/'>HPC2/ELAC2 gene variants associated with incident prostate cancer.</a> November 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14695991/'>Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.</a> December 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14749351/'>The complex genetic epidemiology of prostate cancer.</a> January 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14965441/'>Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.</a> February 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/14982841/'>Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.</a> February 26  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15368467/'>HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.</a> September 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15710417/'>The PcG protein HPC2 inhibits RBP-J-mediated transcription by interacting with LIM protein KyoT2.</a> February 16  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15824169/'>Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.</a> April 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16267836/'>Prevalent mutations in prostate cancer.</a> November 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648113/'>Molecular biology in prostate cancer.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16869093/'>Involvement of the RNAse L gene in prostate cancer.</a> July 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16869076/'>[Preparation of transgenic rats expressing human CD4, CCR5 and MHC class II transactivator and HIV-1 infection of peripheral mononuclear cells].</a> July 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17108325/'>NuMA influences higher order chromatin organization in human mammary epithelium.</a> November 17  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17336131/'>Transcriptional regulation by C-terminal binding proteins.</a> March 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18767027/'>Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20086112/'>Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20086108/'>Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20231859/'>ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21627373/'>Associations of polymorphisms in HPC2/ELAC2 and SRD5A2 genes with benign prostate hyperplasia in Turkish men.</a> October 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21782987/'>Separation-of-function mutation in HPC2, a member of the HIR complex in S. cerevisiae, results in derepression of the histone genes but does not confer cryptic TATA phenotypes.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23141781/'>Genetic analysis of the principal genes related to prostate cancer: a review.</a> August 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23141775/'>A novel p.Leu213X mutation in GJB2 gene in a Portuguese family.</a> July 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23405067/'>Benchmarking human protein complexes to investigate drug-related systems and evaluate predicted protein complexes.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24864115/'>[Hereditary prostate cancer].</a> March 26  2014<br></body></html>
